IDYA IDEAYA Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IDYA

Price (delayed)

$37.46

Market cap

$3.61B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.92

Enterprise value

$3.37B

?
Relative Growth: Rel. Growth: 73
Relative Strength: Rel. Strength: 72
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 44
Highlights
IDEAYA Biosciences's equity has increased by 28% QoQ and by 25% YoY
The company's gross profit rose by 3.9% QoQ
The EPS has surged by 50% year-on-year but it has declined by 22% since the previous quarter
The net income has grown by 47% YoY but it has contracted by 25% from the previous quarter
The quick ratio has decreased by 17% YoY and by 3.2% from the previous quarter
The company's debt rose by 10% YoY and by 2.5% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.ideayabio.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of IDYA

IDYA stock price

How has the IDEAYA Biosciences stock price performed over time
Intraday
-5.67%
1 week
-0.72%
1 month
-5.57%
1 year
44.47%
YTD
8.36%
QTD
0.51%

Financial performance

How have IDEAYA Biosciences's revenue and profit performed over time
Revenue
$234.13M
Gross profit
$234.13M
Operating income
-$216.95M
Net income
-$175.02M
Gross margin
100%
Net margin
-74.8%
IDEAYA Biosciences's operating margin has soared by 98% YoY but it has decreased by 14% from the previous quarter
The company's net margin has surged by 98% YoY but it fell by 20% QoQ
The net income has grown by 47% YoY but it has contracted by 25% from the previous quarter
IDYA's operating income is up by 44% year-on-year but it is down by 18% since the previous quarter

Price vs fundamentals

How does IDYA's price correlate with its fundamentals

Growth

What is IDEAYA Biosciences's growth rate over time

Valuation

What is IDEAYA Biosciences stock price valuation
P/E
N/A
P/B
2.75
P/S
14.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.39
The EPS has surged by 50% year-on-year but it has declined by 22% since the previous quarter
IDEAYA Biosciences's equity has increased by 28% QoQ and by 25% YoY
The stock's P/B is 16% above its 5-year quarterly average of 2.5 and 8% above its last 4 quarters average of 2.7
The stock's price to sales (P/S) is 86% less than its 5-year quarterly average of 113.9 but 18% more than its last 4 quarters average of 13.2
The revenue is up by 3.9% since the previous quarter

Efficiency

How efficient is IDEAYA Biosciences business performance
The return on sales has surged by 98% year-on-year but it has declined by 20% since the previous quarter
The ROA has grown by 49% YoY but it has contracted by 18% from the previous quarter
The company's return on equity rose by 47% YoY but it fell by 18% QoQ
IDYA's ROIC is up by 47% YoY but it is down by 22% from the previous quarter

Dividends

What is IDYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDYA.

Financial health

How did IDEAYA Biosciences financials performed over time
IDEAYA Biosciences's total liabilities has increased by 36% YoY and by 19% from the previous quarter
IDEAYA Biosciences's total assets has increased by 27% QoQ and by 26% YoY
The company's debt is 98% lower than its equity
IDEAYA Biosciences's debt to equity has decreased by 33% QoQ and by 33% YoY
IDEAYA Biosciences's equity has increased by 28% QoQ and by 25% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.